Works matching IS 13518216 AND DT 2008 AND VI 14 AND IP 2

Results: 31

Single 270 μg kg−1-dose rFVIIa vs. standard 90 μg kg−1-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 287, doi. 10.1111/j.1365-2516.2007.01601.x
By:
- Young, G.;
- Shafer, F. E.;
- Rojas, P.;
- Seremetis, S.
Publication type:
Article
Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 323, doi. 10.1111/j.1365-2516.2007.01612.x
By:
- Girolami, A.;
- Ruzzin, E.;
- Tezza, F.;
- Scandellari, R.;
- Scapin, M.;
- Scarparo, P.
Publication type:
Article
A web-based registry of inherited bleeding disorders in the region of Emilia-Romagna: results at three and a half years.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 343, doi. 10.1111/j.1365-2516.2007.01623.x
By:
- Tagliaferri, A.;
- Rivolta, G. F.;
- Biasoli, C.;
- Valdré, L.;
- Rodorigo, G.;
- D'Incá, M.;
- Miratelli, S.;
- Albertini, P.;
- Vincenzi, D.;
- Arbasi, M. C.;
- Marietta, M.;
- Pattacini, C.
Publication type:
Article
Spontaneous intramural haematoma of the sigmoid colon causing acute intestinal obstruction in a haemophiliac: report of a case.
Published in:
2008
By:
- Jarry, J.;
- Biscay, D.;
- Lepront, D.;
- Rullier, A.;
- Midy, D.
Publication type:
Letter
Medullary haemorrhage of the femur as presenting sign of haemophilia in a 22-month-old boy.
Published in:
2008
By:
- Gahr, N.;
- Zeiger, B.;
- Hainmann, I.;
- Uhl, M.
Publication type:
Letter
In vivo models of haemophilia – status on current knowledge of clinical phenotypes and therapeutic interventions.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 248, doi. 10.1111/j.1365-2516.2007.01636.x
By:
- Øvlisen, K.;
- Kristensen, A. T.;
- Tranholm, M.
Publication type:
Article
Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 303, doi. 10.1111/j.1365-2516.2007.01602.x
By:
- Doria, A. S.;
- Lundin, B.;
- Miller, S.;
- Kilcoyne, R.;
- Dunn, A.;
- Thomas, S.;
- Rivard, G.;
- Moineddin, R.;
- BabynABYN, P. S.
Publication type:
Article
Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 260, doi. 10.1111/j.1365-2516.2007.01605.x
By:
- Neunert, C. E.;
- Miller, K. L.;
- Journeycake, J. M.;
- Buchanan, G. R.
Publication type:
Article
Posturographic analysis of balance control in patients with haemophilic arthropathy.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 329, doi. 10.1111/j.1365-2516.2007.01613.x
By:
- Gallach, J. E.;
- Querol, F.;
- González, L. M.;
- Pardo, A.;
- Aznar, J. A.
Publication type:
Article
Prophylaxis for adults with severe haemophilia: a compelling need for evidence-based guidelines.
Published in:
2008
By:
- Walsh, C. E.
Publication type:
Letter
Efficacy of factor VIII/von Willebrand factor concentrate Alphanate® in preventing excessive bleeding during surgery in subjects with von Willebrand disease.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 271, doi. 10.1111/j.1365-2516.2007.01616.x
By:
- Rivard, G. E.;
- Aledort, L.
Publication type:
Article
Perioperative factor IX replacement for surgical resection of a suprasellar astrocytoma in a child with severe haemophilia B.
Published in:
2008
By:
- Walker, J. A.;
- Dixon, N.;
- Gururangan, S.;
- Thornburg, C.
Publication type:
Letter
Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 355, doi. 10.1111/j.1365-2516.2007.01618.x
By:
- Pavlova, A.;
- Diaz-Lacava, A.;
- Zeitler, H.;
- Satoguina, J.;
- Niemann, B.;
- Krause, M.;
- Scharrer, I.;
- Hoerauf, A.;
- Wienker, T.;
- Oldenburg, J.
Publication type:
Article
Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 233, doi. 10.1111/j.1365-2516.2007.01617.x
By:
- Obergfell, A.;
- Auvinen, M.-K.;
- Mathew, P.
Publication type:
Article
One-stage replacement of infected knee prosthesis in a patient with haemophilia A and high titre of inhibitors.
Published in:
2008
By:
- Sartori, R.;
- Bisson, R.;
- Baars, G. W.;
- Petris, U.;
- Radossi, P.;
- Risato, R.;
- Tassinari, C.;
- Tagariello, G.
Publication type:
Letter
The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 295, doi. 10.1111/j.1365-2516.2007.01620.x
By:
- Greninger, D. A.;
- Saint-Remy, J. M.;
- Jacquemin, M.;
- Benhida, A.;
- DiMichele, D. M.
Publication type:
Article
Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 315, doi. 10.1111/j.1365-2516.2007.01621.x
By:
- Unuvar, A.;
- Kavakli, K.;
- Baytan, B.;
- Kazanci, E.;
- Sayli, T.;
- Oren, H.;
- Celkan, T.;
- Gursel, T.
Publication type:
Article
Abstracts of 10th WFH Musculoskeletal Congress.
Published in:
2008
Publication type:
Abstract
Some recent developments regarding arthropathy and inhibitors in haemophilia.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 242, doi. 10.1111/j.1365-2516.2007.01632.x
By:
- Rodriguez-Merchan, E. C.
Publication type:
Article
Treatment of hepatitis C in patients with haemophilia – the Israeli National Hemophilia Center experience.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 336, doi. 10.1111/j.1365-2516.2007.01633.x
By:
- Maor, Y.;
- Schapiro, J. M.;
- Bashari, D.;
- Lurie, Y.;
- Safadi, R.;
- Segol, O.;
- Paritsky, M.;
- Rachlis, Z.;
- Avidan, B.;
- Bar-Meir, S.;
- Martinowitz, U.
Publication type:
Article
European principles of haemophilia care.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 361, doi. 10.1111/j.1365-2516.2007.01625.x
By:
- Colvin, B. T.;
- Astermark, J.;
- Fischer, K.;
- Gringeri, A.;
- Lassila, R.;
- Schramm, W.;
- Thomas, A.;
- Ingerslev, J.
Publication type:
Article
Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
Published in:
2008
By:
- Economou, M.;
- Teli, A.;
- Tzantzaroudi, A.;
- Tsatra, I.;
- Zavitsanakis, A.;
- Athanassiou-Metaxa, M.
Publication type:
Letter
Multiple substitutions at single site: interpreting the effect of Asn92 mutations in human coagulation factor IX.
Published in:
2008
By:
- Sharma, A.;
- Chavali, S.;
- Mahajan, A.;
- Biswas, P.;
- Bharadwaj, D.
Publication type:
Letter
A recurrent F8 mutation in Irish haemophilia A patients: evidence for a founder effect.
Published in:
2008
By:
- Winter, P. C.;
- Egan, H.;
- Mcnulty, O.;
- Jones, F. G. C.;
- O'Donnell, J.;
- Jenkins, P. V.
Publication type:
Letter
A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 281, doi. 10.1111/j.1365-2516.2007.01634.x
By:
- Rubinger, M.;
- Lillicrap, D.;
- Rivard, G. E.;
- Teitel, J.;
- Carcao, M.;
- Hensman, C.;
- Walker, I.
Publication type:
Article
Value added: increasing the power to assess treatment outcome in joint haemorrhages.
Published in:
Haemophilia, 2008, v. 14, n. 2, p. 276, doi. 10.1111/j.1365-2516.2007.01638.x
By:
- Donfield, S. M.;
- Astermark, J.;
- Lail, A. E.;
- Gilbert, S. A.;
- Berntorp, E.
Publication type:
Article
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
Published in:
2008
By:
- Nichols, W. L.;
- Hultin, M. B.;
- James, A. H.;
- Manco-Johnson, M. J.;
- Montgomery, R. R.;
- Ortel, T. L.;
- Rick, M. E.;
- Sadler, J. E.;
- Weinstein, M.;
- Yawn, B. P.
Publication type:
Other
Quality and easy availability of medical support overwhelmingly determines the attitude and belief towards genetic testing in haemophilia.
Published in:
2008
By:
- Ghosh, K.;
- Shelly, S.
Publication type:
Letter
Management of haemophilia in three premature infants.
Published in:
2008
By:
- Kraft, K. E.;
- Verlaak, R.;
- Van Heijst, A. F. J.;
- Nováková, I.;
- Brons, P. P. T.
Publication type:
Letter
Erratum.
Published in:
2008
Publication type:
Correction Notice
Erratum.
Published in:
2008
Publication type:
Correction Notice

Works matching IS 13518216 AND DT 2008 AND VI 14 AND IP 2

Single 270 μg kg<sup>−1</sup>-dose rFVIIa vs. standard 90 μg kg<sup>−1</sup>-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison.

Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.

A web-based registry of inherited bleeding disorders in the region of Emilia-Romagna: results at three and a half years.

Spontaneous intramural haematoma of the sigmoid colon causing acute intestinal obstruction in a haemophiliac: report of a case.

Medullary haemorrhage of the femur as presenting sign of haemophilia in a 22-month-old boy.

In vivo models of haemophilia – status on current knowledge of clinical phenotypes and therapeutic interventions.

Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children.

Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience.

Posturographic analysis of balance control in patients with haemophilic arthropathy.

Prophylaxis for adults with severe haemophilia: a compelling need for evidence-based guidelines.

Efficacy of factor VIII/von Willebrand factor concentrate Alphanate<sup>®</sup> in preventing excessive bleeding during surgery in subjects with von Willebrand disease.

Perioperative factor IX replacement for surgical resection of a suprasellar astrocytoma in a child with severe haemophilia B.

Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls.

Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.

One-stage replacement of infected knee prosthesis in a patient with haemophilia A and high titre of inhibitors.

The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.

Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.

Abstracts of 10<sup>th</sup> WFH Musculoskeletal Congress.

Some recent developments regarding arthropathy and inhibitors in haemophilia.

Treatment of hepatitis C in patients with haemophilia – the Israeli National Hemophilia Center experience.

European principles of haemophilia care.

Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.

Multiple substitutions at single site: interpreting the effect of Asn92 mutations in human coagulation factor IX.

A recurrent F8 mutation in Irish haemophilia A patients: evidence for a founder effect.

A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose.

Value added: increasing the power to assess treatment outcome in joint haemorrhages.

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

Quality and easy availability of medical support overwhelmingly determines the attitude and belief towards genetic testing in haemophilia.

Management of haemophilia in three premature infants.

Erratum.

Erratum.